Laser Adverse Event Protocol: HSV‑1 Reactivation (Peri‑oral & Facial Procedures)

Published:

October 7, 2025

Service: Fotona SP Dynamis (Er:YAG 2940 nm / Nd:YAG 1064 nm) & StarWalker MaQX (QS 1064/532 nm ± dye 585/650 nm).

Cause / Mechanism

Laser disruption of the epidermal barrier and local immune modulation can trigger reactivation of latent herpes simplex virus type 1 (HSV‑1), particularly with peri‑oral/ablative procedures (e.g., Er:YAG fractional or fully ablative resurfacing). Heat, tissue injury and postoperative inflammation facilitate viral replication and spread along trigeminal branches. 1 2

Risk Factors

  • History of recurrent cold sores (even remote); recent outbreak (<6–8 weeks).
  • Peri‑oral procedures; large treatment fields; high ablative depth.
  • Immunosuppression, significant stress/illness, UV exposure.
  • Inadequate peri‑procedural antiviral prophylaxis in high‑risk patients. 1 2 3

Signs & Symptoms

  • Prodrome within 24–72 h: tingling, burning, pruritus at vermilion border or perioral skin.
  • Lesions: grouped vesicles on erythematous base that ulcerate/crust; may extend on treated field.
  • Complications: bacterial superinfection, delayed healing, scarring, autoinoculation to eye (herpetic keratitis—emergency). 1 2

Prevention

  • Screen all patients for history of HSV‑1 and recent episodes during consent.
  • Photoprotection and minimise peri‑oral trauma when possible.
  • Consider peri‑procedural antiviral prophylaxis for high‑risk cases (history of cold sores, peri‑oral ablative/fractional resurfacing, large fields). Follow Australian guidance and individualise to renal function, interactions and pregnancy status. 1 2 3

Management Protocol

Immediate Actions (suspected outbreak):

  • Commence antiviral therapy promptly (e.g., valaciclovir or aciclovir per Australian guidelines). 1 2
  • Educate on contagion: avoid touching lesions; frequent hand hygiene; avoid sharing towels; avoid oral contact.
  • Pain control; non‑adhesive dressings if erosions; avoid occlusive cosmetics until crusted.
  • If ocular symptoms (eye pain, photophobia, vision change): urgent same‑day ophthalmology—risk of herpetic keratitis. 4

Suggested Peri‑procedural Prophylaxis Regimens (refer to current Australian guidance; examples):

  • Valaciclovir: initiate day before or morning of procedure and continue 3–7 days post‑procedure (typical total course 5–7 days). 1 2
  • Aciclovir: alternative where valaciclovir contraindicated; similar timing/duration as above. Doses vary by indication, renal function and risk profile—follow national guidelines and product information. 1 2

Escalation / Referral:

  • Extensive facial involvement, immunocompromised host, failure to respond within 48–72 h, or suspected eczema herpeticum → urgent GP/dermatology/ID review.
  • Ocular involvement or lesions near eye → urgent ophthalmology. 4

Follow‑up & Documentation

  • Document history (previous HSV), prophylaxis offered/used, onset timing, photos, and treatment given.
  • Provide written aftercare and recurrence prevention advice (stress/UV reduction, prompt therapy at prodrome).
  • Review within 2–5 days (earlier if peri‑ocular).
  • Record incident in Laser Log; include in morbidity & mortality/quality review. 3

Sources

  1. Australian STI Management Guidelines (ASHM). Genital herpes simplex virus (HSV) — systemic guidance including dosing principles (relevant to HSV‑1)., viewed 7 October 2025, https://sti.guidelines.org.au/sexually-transmissible-infections/genital-herpes-simplex-virus-hsv/ ↩︎
  2. Melbourne Sexual Health Centre (MSHC). Herpes treatment guidelines — dosing and prophylaxis considerations., viewed 7 October 2025, https://www.mshc.org.au/health-professionals/treatment-guidelines/herpes-treatment-guidelines ↩︎
  3. Ahpra & National Boards (2025). Guidelines for practitioners who perform non-surgical cosmetic procedures — patient screening, consent and peri‑procedural risk reduction., viewed 7 October 2025, https://www.ahpra.gov.au/Resources/Cosmetic-surgery-hub/Cosmetic-procedure-guidelines.aspx ↩︎
  4. RANZCO. Ocular emergencies and laser safety — risk of herpetic keratitis in peri‑ocular lesions., viewed 7 October 2025, https://ranzco.edu ↩︎
Author:
Dr. Bart Scanlon
Medical Practitioner
Medical Registration Number: MED00019402249

Newcastle Cosmetic Doctor

The clinic for everybody.

Opening Hours

envelopemap-markersmartphone